Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Jingda Biotechnology is a specialized biotechnology firm based in Beijing, China, that operates as a key supplier and contract research organization for the life sciences and diagnostic sectors. The company leverages a suite of advanced platforms, including single-cell antibody discovery and mammalian cell protein expression, to develop high-performance recombinant proteins and monoclonal antibodies. Their product portfolio is primarily focused on the in vitro diagnostics (IVD) market, providing critical raw materials for assays in oncology, infectious disease, and cardiology. Beyond manufacturing, Jingda Biotech offers customized services in antibody engineering and phage display to support therapeutic drug discovery efforts. The company is recognized as a national high-tech enterprise, maintaining a strong presence in the Beijing pharmaceutical R&D ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Jingda Biotechnology.